ID: PMRREP33297
Format: PPT*, PDF, EXCEL
Last Updated: 12 May 2025
Industry: Food and Beverages
Number of Pages: 201
Newly-released Celadrin Supplements Market analysis report by Persistence Market Research reveals that global sales of Celadrin Supplements in 2025 were held at US$ 504.4 Million. With a 7.3% projected CAGR from 2025 to 2032, the market is expected to reach a valuation of US$ 826 Million by the end of the forecast period.
|
Attributes |
Details |
|
Global Celadrin Supplements Size (2025) |
US$ 504.4 Million |
|
Global Celadrin Supplements Size (2032) |
US$ 826 Million |
|
Global Celadrin Supplements CAGR (2025-2032) |
7.3% |
| Historical Market Growth Rate (CAGR 2019 to 2024) |
6.0% |
|
Key Companies Covered |
|
As per the Celadrin Supplements Market research by Persistence Market Research - a market research and competitive intelligence provider, historically, from 2019 to 2024, the value of Celadrin Supplements increased at around 6.0% CAGR. With an absolute dollar opportunity of US$ 475.8 Million, the market is projected to reach a valuation of US$ 826 Million by 2032.
Celadrin is a topical analgesic that can be bought without a prescription. The primary ingredient is menthol, and it also contains cetylated and esterified fatty acids. It is a lotion used to treat osteoarthritis, bruising, sprains, and other joint and muscle pains. Arthritis is the 3rd most raising condition after diabetes and dementia which is associated with disability.
There are around 100 types of arthritis. Osteoarthritis is one of the most common arthritis in which the soft tissue called cartilage that works as a protective layer between the joints degrades mostly due to the wear and tear of the body. Thus, it is a common condition in people aged above 50 years, though it may occur at a young age due to past joint injury.
Celadrin supplements are used to cure this condition. It is recommended for a person having arthritis, joint pain, or psoriasis. It is either in a form of capsules or gel which are available in retail stores as well as on online platforms.
According to the Centres for Disease Control and Prevention, more than 32.5 adults in the U.S. are suffering from osteoarthritis. It is estimated that 1 in 4 US adults have arthritis which accounts for about 54.4 million people. By 2040, it is projected that this number will reach 78 million.
Around 80% of elderly people who are 55 years of age and older may have osteoarthritis that is detectable on an X-ray. Around 60% of them reportedly exhibit symptoms. It is estimated that 240 million people worldwide experience osteoarthritis symptoms. Rheumatoid arthritis is another form of arthritis that affect nearly 14 million people worldwide. Compared to men, post-menopausal women have a high chance of getting knee osteoarthritis. The increasing number of arthritis patients will accelerate the growth of celadrin supplements demand.
North America had a market size of US$ 167.3 Million in 2024 and it has US$ 180.9 Million in 2025. It is projected that the market in North America will be worth US$ 366.3 Million by 2032.
Osteoarthritis is commonly found in older generation people. In Canada, there are more than 861 thousand people in the age group 85 and above which is more than twice the number in 2019. There is a 12% increase in this age group since 2019. Thus, with the increase in the aged population, the frequency and burden of disability caused by osteoarthritis are expected to rise in Canada as the population ages and grows. More than 3.9 million people are detected with osteoarthritis in Canada. These factors will have a significant effect on the market.
United States Celadrin Supplements Market Analysis:
The market in the United States is expected to grow to be worth US$ 285.7 Million with an absolute dollar growth of US$ 128.7 Million from 2025 to 2032. The market in the United States has grown at a CAGR of 6.7% from 2019 to 2024 and is expected to grow at a CAGR of 6.2% from 2025 to 2032.
Celadrin supplements are also used in the treatment of Psoriasis. Due to psoriasis, an immune-mediated illness, the body creates new skin cells more quickly-in days as opposed to weeks. People in the age group 15 to 35 years are likely to get affected by psoriasis. Around 8 million people are affected by psoriasis in the U.S.
United Kingdom Celadrin Supplements Unit Market Analysis:
The market in the United Kingdom is expected to grow to be worth US$ 45.6 Million with an absolute dollar growth of US$ 21.3 Million from 2025 to 2032. The market in the United Kingdom grew at a CAGR of 7.1% from 2019 to 2024 and is expected to grow at a CAGR of 6.5% from 2025 to 2032.
In the U.K. around 8.5 million people have osteoarthritis, whereas more than 10 million people suffer from back pain. Also, 1% of the population in the UK has rheumatoid arthritis, according to the most recent statistics from a 2020 study by the National Institute for Health and Care Excellence (NICE). Celadrin supplements are prominently used for pain relief. Thus, owing to this data the market will experience a rise in demand in the coming years.
China Celadrin Supplements Market Analysis:
In China, the market is expected to grow to be worth US$ 76.9 Million with an absolute dollar growth of US$ 42.2 Million. The market in the country has grown at a CAGR of 9.7% from 2019 to 2024 and is expected to grow at a CAGR of 8.3% from 2025 to 2032.
China has the largest older age population in the world, wherein around 254 million people in 2024 were in the age group 65 years and above. This number is expected to increase to 402 million by 2040 which will constitute about 28% of the population. In 2019, according to WHO, 75% of older people suffer from this non-communicable disease. As arthritis is common among the older age, thus for its cure there will be demand for Celadrin supplements.
Japan Celadrin Supplements Market Analysis:
The market in Japan is expected to grow to be worth US$ 64.9 Million with an absolute dollar growth of US$ 31.1 Million. The market in the country grew at a CAGR of 7.5% from 2019 to 2024 and is expected to grow at a CAGR of 6.7% from 2025 to 2032.
In Japan, aged people who belong to 65 years and over made up 36.2 million people in 2024, which was a record-high 28.9% of the total population. The older age population is significantly increasing in Japan. It has the highest senior population ratio globally. Due to this, the number of patients having osteoarthritis is also high in the country, thereby affecting the demand positively.
Which form of Celadrin Supplements is projected to Witness the Fastest Growth?
The capsule form of celadrin supplements is projected to witness the fastest growth as it has grown at a CAGR of 8% from 2019 to 2024 and is expected to grow at a CAGR of 7.2% from 2025 to 2032.
Celadrin tablets are composed of cetyl myristoleate, eicosapentanoic acid, and docosahexanoic acid. The celadrin pill consistently supports joint performance. It improves the general health of the structural system, encourages healing, and lowers discomfort. The demand for celadrin capsules is increasing owing to the increasing number of health issues related to joint and muscle pain.
Key players in the Celadrin supplements market are Now Foods, Ergomax, Ashland, Pacific Rainbow International Inc., RichesM Healthcare, Life Extension, Abbott Laboratories Incorporation, Pfizer Inc., Bayer AG, and Eli Lilly and Company.
Some of the recent developments in the Celadrin supplements market are:
By Form
By Application
By Sales Channel
By Region
The global market value reached US$ 504.4 Million in 2025.
It is projected to reach US$ 826 Million by 2032.
The market is expected to grow at a CAGR of 7.3%
Capsules are the fastest-growing form, with a projected CAGR of 7.2%.
North America holds the largest market share, expected to reach US$ 366.3 Million by 2032.
Key players include Bayer AG, Pfizer Inc., Abbott, Now Foods, and Eli Lilly.
For more information on this report and its delivery timelines please get in touch with our sales team.
